Celldex · 9 hours ago
Associate Director, US/Global Forecasting - Hampton, NJ
Hampton, NJ
Full-time
Onsite
Senior Level, Lead/Staff, Director/Executive
$154K/yr - $200K/yr
6+ years expCelldex is pioneering new horizons in immunology to deliver life-changing therapies. The Associate Director of US/Global Forecasting will be responsible for building and maintaining operational forecasting models for barzolvolimab and collaborating cross-functionally to ensure alignment on forecast assumptions.
BiotechnologyHealth CareOncologyPharmaceutical
Responsibilities
Build, update, and maintain the operational forecasting models for barzolvolimab including scenario planning, sensitivity analysis, and risk assessments in the US and outside of the US across disclosed and undisclosed indications
Collaborate cross-functionally with market research to build demand-based forecasts
Further development and ensure assumption alignment across functions (including Insights, Market Access, Marketing, Sales, Supply Chain, etc.)
Present forecasting assumptions, logic, and outputs to senior leadership and the executive team, where appropriate
Guide the design of primary market research studies to validate or create forecast assumptions
Conduct epidemiological and claims-based studies to determine the size of market opportunities
Support other financial analysis efforts
Qualification
Required
Bachelor's degree in a relevant field or equivalent in experience (e.g., Finance, Economics, Engineering, Statistics, Pharmacy, or Life Sciences)
Advanced degree strongly preferred (MBA, MD, PharmD, PhD, or Masters in Biostatistics/Quantitative discipline)
A minimum of 6 years of relevant experience in forecasting, market research, strategic planning, and/or management consulting; previous biotech industry experience is preferred
Minimum of 3 years' experience serving as the single source of truth for commercial revenue expectations in a forecasting role for the US and outside of US markets, including responsibility for an operational forecast
Expert-level Excel modeling (both short-range and long-range forecasting, sensitivity analysis, scenario tools, operational forecasting)
Firm understanding of forecasting methodologies in pharma/biotech: prevalence-based, incidence-based, TRx-based, patient flow, analog-based, etc
Ability to deliver these responsibilities in a highly dynamic market environment, including effectively generating forecasting/modeling scenarios through periods of disruption and discontinuity, including new market approvals and biosimilar entrants
Ability to understand and translate market insights, qualitative research, access data, and competitive intelligence into quantifiable inputs
Cross-functional collaboration and communication
Well organized and analytical with high attention to detail
Extensive experience with IQVIA, Komodo Health, Symphony, or similar data sets
Extensive experience with forecasting methodologies and quantitative techniques including smoothing, regression, time series analyses, Monte-Carlo simulations preferred
Proven track record of building and defending forward-looking commercial forecasts that inform product positioning and strategy, resource allocation, and prioritization in a dynamic environment
Direct experience supporting a launch is preferred
Experience in specialty biologics, immunology, or rare diseases is preferred
Prior experience with pricing/access inputs, cross-functional forecast alignment and global forecasting coordination is preferred
Travel Required – Up to 10%
Benefits
Annual discretionary bonus
Long term incentive
401(K) plan with employer contribution
Health care and other insurance benefits (for employee and family)
Paid holidays
Vacation
Sick days
Company
Celldex
Celldex is pioneering new horizons in immunology to deliver life-changing therapies.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$1.54B2024-02-29Post Ipo Equity· $460.5M
2023-11-07Post Ipo Equity· $200.5M
2021-07-12Post Ipo Equity· $287.5M
Leadership Team
A
Anthony Marucci
President & CEO
Ronald A. Pepin
Senior Vice President and Chief Business Officer
Recent News
2025-11-16
Company data provided by crunchbase